AQR Capital Management
CRBU icon

AQR Capital Management’s Caribou Biosciences CRBU Stock Holding History

AQR Capital Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$29.8K Sell
15,678
-9,883
-39% -$17K ﹤0.01% 3726
2025
Q4 		$40.6K Sell
25,561
-35,846
-58% -$75.2K ﹤0.01% 3521
2025
Q3 		$143K Sell
61,407
-585,718
-91% -$1.11M ﹤0.01% 3321
2025
Q2 		$815K Buy
647,125
+121,247
+23% +$119K ﹤0.01% 2318
2025
Q1 		$480K Buy
525,878
+463,391
+742% +$602K ﹤0.01% 2446
2024
Q4 		$99.4K Sell
62,487
-51,238
-45% -$103K ﹤0.01% 2764
2024
Q3 		$223K Buy
113,725
+95,384
+520% +$195K ﹤0.01% 2520
2024
Q2 		$30.1K Buy
+18,341
New +$58.6K ﹤0.01% 2560

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AQR Capital Management's CRBU Position: Q1 2026 in Review

AQR Capital Management reduced its Caribou Biosciences (CRBU) stake by 39% in Q1 2026, selling an estimated $17K and leaving 15,678 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3726.

AQR Capital Management first reported a position in CRBU in Q2 2024 and has held it in 8 quarters since. The position peaked at $815K in Q2 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • AQR Capital Management held 15,678 shares of Caribou Biosciences worth $29.8K as of Q1 2026.
  • AQR Capital Management sold 9,883 Caribou Biosciences shares in Q1 2026, an estimated $17K.
  • Caribou Biosciences made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #3726 holding.
  • AQR Capital Management first reported a position in Caribou Biosciences in Q2 2024 and has held it in 8 quarters since.
  • AQR Capital Management's Caribou Biosciences position peaked at $815K in Q2 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.